Session Information
Date: Friday, November 15, 2019
Session Title: Spine and Pain Case and Research Report
Session Time: 12:30pm-2:00pm
Location: Research Hub - Kiosk 7
Disclosures: Catherine Jameson, DO: Nothing to disclose
Objective: Platelet rich plasma (PRP) has become a main component of regenerative medicine and here we present an approach to treating chronic tibialis anterior (TA) tendon/muscle pain with PRP. Our goal is to determine the effectiveness of PRP in treating anterior ankle pain after failed traditional conventional therapeutic treatments.
Design: Retrospective Chart Review
Setting: Outpatient Interventional Pain Clinic
Participants: Ages 18 or greater, both genders, tibialis anterior tendon pain for > 6 months, failed conservative therapies with no long-term improvement, and had not undergone previous regenerative injections.
Interventions: Ultrasound-guided PRP tibialis anterior tendon injection
Main Outcome Measures: Numeric Rating Scale (NRS) pre and post injection Opioid Dosage Reduction
Results: The average pain score at baseline was 8±1.5 on NRS scale. The average percent change in pain between baseline and 8 weeks post treatment was 36±23.2% reduction or improvement. There was a significant reduction or improvement in pain at 8 weeks post PRP treatment when compared with baseline, P=.008, according to the self-report percent change in pain. The average opioid reduction between baseline and 8 weeks post treatment was 17±21.2%. Three of the patients who were on opioid pain medications did not change the dosage of opioids after 8 weeks PRP treatment. No significant change in opioid reduction after 8 weeks post PRP treatment was shown in this study when compared with baseline, P=.063.
Conclusions: Platelet-rich plasma (PRP) has become an increasingly popular novel approach for physicians to treat chronic musculoskeletal pain. Our study demonstrated that its use in chronic tibialis anterior pain showed that 8 weeks post PRP treatment significantly improved chronic tibialis anterior pain. In addition, there was a difference in opioid dosages between at baseline and 8 weeks post-PRP treatment. Although not statistically significant, the study suggested a tendency of lower opioid pain medication dosages after 8 weeks post-PRP treatment.
Level of Evidence: Level IV
To cite this abstract in AMA style:
Jameson C, Chen CR, Aydin S. Application of Platelet Rich Plasma to Chronic Tibialis Anterior Pain: A Case Series Presentation [abstract]. PM R. 2019; 11(S2)(suppl 2). https://pmrjabstracts.org/abstract/application-of-platelet-rich-plasma-to-chronic-tibialis-anterior-pain-a-case-series-presentation/. Accessed October 8, 2024.« Back to AAPM&R Annual Assembly 2019
PM&R Meeting Abstracts - https://pmrjabstracts.org/abstract/application-of-platelet-rich-plasma-to-chronic-tibialis-anterior-pain-a-case-series-presentation/